BSEInsider Trading / SAST22h ago · 30 Oct 2026, 05:38 pm
Trading Window Closure Under SEBI (Prohibition of Insider Trading) Regulations, 2015
Medplus Health Services Ltd · 543427
✦ AI Summaryinsider_trading
Medplus Health Services Ltd has announced the closure of its trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of a Board meeting to consider a proposal for buying back its equity shares. The trading window will be closed from October 30, 2026, until 48 hours after the outcome of the Board meeting is made public. The company has also informed that the Board meeting will be held on November 06, 2026, to consider the buy-back proposal and related matters.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medplus Health Services Ltd - 543427 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
bbf09b0d-d474-4072-b3a0-12bd8e2f2346.pdf
View document text
MedPlus Health Services Limited
October 30, 2026
The Listing Department The Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza,
Dalal Street, Fort, Bandra Kurla Complex,
Mumbai 400 001 Bandra (East), Mumbai – 400 051
BSE Scrip Code Equity: 543427 NSE Symbol: MEDPLUS
Dear Sir/ Madam,
Sub: Intimation of Board Meeting to consider Buy-back of equity shares
Ref.: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
("SEBI LODR ") and Trading Window Closure under SEBI (Prohibition of Insider Trading)
Regulations, 2015.
Pursuant to Regulation 29 of the SEBI LODR, we would like to inform that the Meeting of the Board of
Directors of the Company is scheduled to be held on Friday, November 06, 2026, to consider, inter-
alia, a proposal of buy back of the fully paid-up equity shares of the Company including matters
related/incidental thereto in accordance with the provisions of Sections 68, 69, and 70 of the
Companies Act, 2013, read with rules made thereto and the Securities and Exchange Board of India
(Buy-back of Securities) Regulations, 2018, as amended.
Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and
Company’s Code of Conduct for Prevention of Insider Trading, the trading window for the Designated
Persons of the Company and including their immediate relatives, will be closed from Friday, 30
October 2026, till 48 hours after the outcome of the Board Meeting in relation to the proposal for buy
back of the fully paid-up equity shares of the Company, is made public.
The same will be available on the website of the Company at www.medplusindia.com and also on the
websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and
www.nseindia.com respectively.
Kindly take the same on records.
Thanking You
Yours faithfully
For MedPlus Health Services Limited
Shrenik Soni
Company Secretary & Compliance Officer
ICSI M. No. F12400
040-6724 6724
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com